Facebook
X
LinkedIn
ForwardDEA MATE Act Substance Use Disorder 4-Activity Package
The recently enacted Medication Access and Training Expansion (MATE) Act, requires that Drug Enforcement Administration (DEA)-registered health care providers (except those in exclusive veterinary practice) complete training on the treatment and management of opioid or other substance use disorders.
This mandated eight (8) hours of enduring education is a one-time requirement and can be fulfilled using one or more continuing education (CE) activities related to opioid and other substance use. Evidence of completed education will be requested after June 27, 2023 whenever a provider applies for a new or renewed DEA registration to be a licensed prescriber of controlled substances.
Target Audience
All Drug Enforcement Administration (DEA)-registered practitioners who treat patients with opioid or other substance use disorders, including physicians, nurse practitioners, physician assistants, and dentists.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
Activity 1 – Defining and Managing Pain
- Describe a multidimensional definition of pain that includes the influences originating from three biopsychosocial dimensions.
- Differentiate between acute, subacute, and chronic pain when describing the pain experience.
- Review the rationale supporting the consistent use of validated assessment instruments when assessing pain.
- Describe the recommended decision process to be used when determining whether or not to initiate opioids for pain management
- Describe the types and formulations of opioid drugs that are recommended for use in an outpatient or community setting.
- Outline potential benefits, risks, and harms when prescribing opioids.
- Describe clinical practice recommendations to prevent patient harm when prescribing opioids.
- Recognize the many nonopioid medications and nonpharmacologic interventions that can be used to treat pain.
Activity 2 – Identifying and Managing Patients with Substance Use Disorder (SUD)
- Discuss the use of validated screening tools and the assessment/diagnosis of individuals who screen positive for substance use disorder.
- Review strategies for the initiation and management of FDA-approved medications for substance use disorder.
- Develop effective patient and family education plans that incorporate how to identify the signs of overdose, patient safety, overdose prevention, and the storage and use of naloxone.
Activity 3 – Safe and Effective Pain Management Utilizing Opioid Therapy
- Review the assessment and treatment of patients with acute, subacute, or chronic pain.
- Develop effective treatment plans and interprofessional treatment interventions.
- List current recommendations and strategies for the management of pain in patients utilizing opioid therapy.
- Recognizing signs and symptoms of opioid use disorder (OUD).
Activity 4 – Overcoming Barriers in the Management of Patients with Opioid Use Disorder (OUD)
- Describe treatment planning techniques using patient-centered decision-making and evidence-based communication strategies.
- Identify the three types of stigmas and their effect on patients with mental health disorders, substance use disorders (SUD), and in particular patients with opioid use disorder (OUD).
- Discuss legal, ethical, and privacy issues involved in the care of clients with opioid use disorder (OUD).
Commercial Support
There is no commercial support for this activity.
Course summary
Activities 1 and 2: Mary Kathleen Ebener PhD, RN
Activities 3 and 4: Margaret A. Clark, MSc, RN, RRT – NPS, CMPP
Planners and Reviewers
Dorothy Caputo, MA, BSN, RN (President, AKH Inc.)
Michele Bielarski, RN (planner/reviewer)
Bernadette Marie Makar, MSN, APRN, BC, NP-C (Reviewer)
Risha Bellomo, PA-C (Reviewer)
AKH Inc Staff and Planners
All of the relevant financial relationships listed for these individuals have been mitigated.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
In support of improving patient care, AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive up to 8.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Price
Criteria for Success for Each Activity
To obtain credit, you must participate in the entire activity. Partial credit is not awarded. Complete the post test and evaluation. You must receive a 70% or more on the post test to pass. The Certificate of Completion is immediately available for download after submitting your evaluation. It will remain in your profile transcript for future retrieval if needed. It can be found under My Account > My Activities > Completed Activities.
If you have any questions, contact [email protected].